ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

ETNB 89bio Inc

9,22
0,36 (4,06%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
89bio Inc ETNB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,36 4,06% 9,22 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
9,19 8,90 9,35 9,22 8,86
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/3/202423:06EDGAR2Form NT 10-K - Notification of inability to timely file Form..
01/3/202423:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:10EDGAR2Form 8-K - Current report
24/2/202402:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202417:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202403:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:43EDGAR2Form 8-K - Current report
08/12/202312:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202322:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202322:02EDGAR2Form 8-K - Current report
04/12/202313:01EDGAR2Form 8-K - Current report
27/11/202314:01EDGAR2Form 8-K - Current report
14/11/202322:30EDGAR2Form 8-K - Current report
09/11/202321:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202302:41EDGAR2Form 8-K - Current report
21/9/202315:07DJN89bio Gets FDA Breakthrough Designation for Pegozafermin in..
12/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:27EDGAR2Form 8-K - Current report
09/8/202322:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:12EDGAR2Form 8-K - Current report
06/7/202302:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

Delayed Upgrade Clock